# NIH Funds Minneapolis-Based Senphonix Platform

On October 13, 2026, the National Institutes of Health (NIH), through the National Heart, Lung, and Blood Institute (NHLBI), announced an SBIR Phase I award to Minneapolis-based Senphonix for its SleeveSense continuous vital-signs monitoring platform. Award R43HL184398 supports software development and clinical testing, cloud and database scalability, and cybersecurity work toward SOC 2 Type II readiness; the award amount was not disclosed. Senphonix expects to begin a clinical study in late 2026 or early 2027 and plans to pursue FDA 510(k) clearance in early to mid-2027. The device remains in development and is not cleared for sale. This follows a September 2026 NSF STTR Phase I award for SleeveSense hardware and software development.

- The NIH award funds early-stage development rather than a product acquisition; healthcare systems and technology firms should distinguish this research-stage platform from a cleared product or current purchasing opportunity.
- Companies pursuing health-monitoring pilots or partnerships can assess potential future fit, while recognizing that the clinical study and planned FDA 510(k) submission have not yet occurred.
- Senphonix’s work on cloud scalability and cybersecurity readiness may be relevant to organizations evaluating future connected-care platforms, but the signal does not identify an open solicitation or a disclosed award value.

**Jurisdictions:** federal
**Industries:** Healthcare, Information Technology
**Topics:** Regulatory Compliance, Cloud Services
**Published:** October 13, 2026

### Government Entities
- U.S. National Institutes of Health (NIH)
- National Heart, Lung, and Blood Institute (NHLBI)
- National Science Foundation (NSF)
- U.S. Food and Drug Administration (FDA)

### Vendors
- Senphonix, Inc. (awardee)

### Key Quotes
> What convinced me about SleeveSense is that this team went after those friction points head-on, setting out to design around every one of them.
> — Mark Koppel, MD, founding member of the Senphonix advisor team

### Sources
- [Senphonix Receives National Institutes of Health Grant to Advance SleeveSense, a Continuous, Long-Term Vitals Monitoring Platform](https://www.prnewswire.com/news-releases/senphonix-receives-national-institutes-of-health-grant-to-advance-sleevesense-a-continuous-long-term-vitals-monitoring-platform-302906600.html) - PR Newswire